2022
DOI: 10.14309/01.ajg.0000863240.15742.72
|View full text |Cite
|
Sign up to set email alerts
|

S1650 The Influence of Non-Alcoholic Fatty Liver Disease (NAFLD) on Peptic Ulcer Disease Hospitalizations: A Comparative Analysis in the United States

Abstract: Table 1. Helicobacter pylori confirmation testing outcomes in the pre-pharmacy intervention group and post-pharmacy intervention groups after treatment Confirmation Test Result Pre-Pharmacy Post-Pharmacy Indeterminate 0 (0.0%) 3 (3.1%) Not Done 4 (10.5%) 23 (24.0%) Negative 23 (60.5%) 62 (64.6%) Positive 11 (28.9%) 7 (7.3%) P-value 5 0.

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles